Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 25

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Retinal blood flow variations after an intense and prolonged exercise (marathon)

Martine Mauget Faysse; Nicolas Arej; Bruno Lay; Kevin Zuber; Sophie Thevenin; Anne-Sophie Alonso; Justine Lafolie; Laurence Salomon; Sabine Derrien; Vivien VASSEUR

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5269.

ARVO Annual Meeting Abstract July 2019

A new association: Acute macular neuro retinopathy in acute optic neuritis

Martine Mauget-Faysse; Vivien VASSEUR; Romain Deschamps; Laurence Salomon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2278.

ARVO Annual Meeting Abstract July 2019

3D Image Processing and Image Display of the Vascular Network in OCT-Angiography images

Vivien VASSEUR; Martine Mauget-Faÿsse; Laurence Salomon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3085.

ARVO Annual Meeting Abstract June 2017

Aflibercept polypoidal choroidal vasculopathy treatment : Result of a prospective study

Martine Mauget-Faysse; Vasseur Vivien; Armelle Cahuzac; Florence Coscas; Laurent CASTELNOVO; Catherine Favard; Guillaume Michel; Catherine Français; Laurence Salomon; Benjamin Wolff

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3201.

ARVO Annual Meeting Abstract September 2016

Retinal Microvascular Alterations Related To Diabetes assessed by Optical Coherence Tomography Angiography.

Julien Gozlan; Martine Mauget-Faysse; Olivier Lichtwitz; Nicolas Leveziel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract June 2015

Real Life of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study

Salomon Y Cohen; Catherine P Garcher; Jean-Francois Korobelnik; Laurent Kodjikian; Ramin Tadayoni; Michel Weber; Martine Mauget-Faysse; Sam Razavi; Joel Uzzan; ingrid Dufour

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4601.

ARVO Annual Meeting Abstract June 2013

Inner nuclear layer microcystic changes in optic nerve atrophy: a prospective study

Benjamin Wolff; Vivien Vasseur; Chrysanthi Basdekidou; Jose Sahel; Catherine Vignal; Martine Mauget-Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6347.

ARVO Annual Meeting Abstract March 2012

En Face Oct Imaging As A Complementary Diagnostic Instrument For Type 2a Retinal Telangiectasies

Chrysanthi Basdekidou; Benjamin Wolff; Vivien Vasseur; Jose-Alain Sahel; Martine Mauget-Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):833.

ARVO Annual Meeting Abstract March 2012

En-face OCT Imaging For The Diagnosis Of Outer Retinal Tubulations In Age-related Macular Degeneration

Benjamin Wolff; alexandre matet; Chrysanthi Basdekidou; vivien vasseur; Jose A. Sahel, Jr.; Martine Mauget-Faysse

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2656.

ARVO Annual Meeting Abstract April 2011

Phase I MP0112 Wet AMD Study Imaging Results: Darpin® MP0112 Shows Potential For Quarterly Dosing In Wet AMD

Eric H. Souied; Martine Mauget-Faysse; Francois Devin; Ute E. Wolf-Schnurrbusch; Michael T. Stumpp; Sebastian Wolf; MP0112 wet AMD study group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3541.

ARVO Annual Meeting Abstract April 2011

Phase I Mp0112 Wet AMD Study: Results Of A Single Escalating Dose Study With DARPin® MP0112 In Wet AMD

Sebastian Wolf; Eric H. Souied; Martine Mauget-Faysse; Francois Devin; Manjula Patel; Ute E. Wolf-Schnurrbusch; Michael Stumpp; MP0112 wet AMD study group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1655.

ARVO Annual Meeting Abstract April 2010

Retinal Cysts in Age-Related Macular Degeneration: An Oct Study

B. Wolff; M. Quaranta El Maftouhi; M. Mauget Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4929.

ARVO Annual Meeting Abstract April 2009

Superoxyde Dismutase in Antioxydant Treatment of Armd

R. Hera; C. Puech; M. Mauget-Faysse; X. Leverve; H. Roth; C. Chiquet; J. Romanet

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):258.

ARVO Annual Meeting Abstract May 2008

Anti-VEGF Intravitreal Injections for Myopic Choroidal Neovascularization

M. El Maftouhi-Quaranta; M. Mauget-Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5584.

ARVO Annual Meeting Abstract May 2008

Anti VEGF Treatment of Classic Choroidal Newvessels in Age Related Macular Degeneration

C. M. Favard; M. M. Mauget-Faÿsse; C. C. Français; G. G. Coscas

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):344.

ARVO Annual Meeting Abstract May 2006

Photodynamic Therapy in the Treatment of Choroidal Metastasis From a Lung Adenocarcinoma

M. Mauget–Faysse; M. Quaranta–El Maftouhi; J. Gambrelle

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4710.

ARVO Annual Meeting Abstract May 2006

Retrospective Analysis of OCT Signs Predicting Retinal Pigment Epithelial Rip in AMD

M. Quaranta–El; A. El Maftouhi; M. Mauget Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2156.

ARVO Annual Meeting Abstract May 2005

Evolutional Classification of Idiopathic Polypoidal Choroidal Vasculopathy According to Fluorescein Angiographic and OCT Findings

M. Quaranta; M. Mauget–Faÿsse

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):226.

ARVO Annual Meeting Abstract May 2005

Verteporfin Photodynamic Therapy (PDT) of CNV Associated With Toxoplasma Retinochoroiditis

A.M. Leys; M. Mauget–Faÿsse; G. Mimoun; J.M. Ruiz–Moreno; M. Quaranta; G. Soubrane; L. Postelmans; M. Defauchy; J.J. De Laey

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):341.

ARVO Annual Meeting Abstract May 2004

Photodynamic therapy with verteporfin for idiopathic polypoidal choroidal vasculopathy. Preliminary results.

M. Mauget–Faysse; M. Quaranta; A. Leys; E. de La Marnierre

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):5268.

1 2

Next 20 Results »

Advertisement